BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26164273)

  • 1. Temporal Dissociation of Striatum and Prefrontal Cortex Uncouples Anhedonia and Defense Behaviors Relevant to Depression in 6-OHDA-Lesioned Rats.
    Matheus FC; Rial D; Real JI; Lemos C; Takahashi RN; Bertoglio LJ; Cunha RA; Prediger RD
    Mol Neurobiol; 2016 Aug; 53(6):3891-3899. PubMed ID: 26164273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanosine prevents depressive-like behaviors in rats following bilateral dorsolateral striatum lesion induced by 6-hydroxydopamine.
    Marques NF; Binder LB; Roversi K; Sampaio TB; Constantino LC; Prediger RD; Tasca CI
    Behav Brain Res; 2019 Oct; 372():112014. PubMed ID: 31212060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased synaptic plasticity in the medial prefrontal cortex underlies short-term memory deficits in 6-OHDA-lesioned rats.
    Matheus FC; Rial D; Real JI; Lemos C; Ben J; Guaita GO; Pita IR; Sequeira AC; Pereira FC; Walz R; Takahashi RN; Bertoglio LJ; Da Cunha C; Cunha RA; Prediger RD
    Behav Brain Res; 2016 Mar; 301():43-54. PubMed ID: 26707254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease.
    Tadaiesky MT; Dombrowski PA; Figueiredo CP; Cargnin-Ferreira E; Da Cunha C; Takahashi RN
    Neuroscience; 2008 Oct; 156(4):830-40. PubMed ID: 18817851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin.
    Santiago RM; Barbiero J; Gradowski RW; Bochen S; Lima MM; Da Cunha C; Andreatini R; Vital MA
    Behav Brain Res; 2014 Feb; 259():70-7. PubMed ID: 24183944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent anomaly in mesocorticolimbic dopaminergic circuits might be associated with different depressive behaviors, an animal study.
    Bai M; Zhu X; Zhang L; Zhang Y; Xue L; Wang Y; Zhong M; Zhang X
    Brain Behav; 2017 Oct; 7(10):e00808. PubMed ID: 29075568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine.
    Santiago RM; Barbieiro J; Lima MM; Dombrowski PA; Andreatini R; Vital MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1104-14. PubMed ID: 20547199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Age-related changes in behavior, in monoamines and their metabolites content, and in density of D1 and D2 dopamine receptors in the brain structures of WAG/Rij rats with depression-like pathology].
    Sarkisova KY; Kulikov MA; Kudrin VS; Midzyanovskaya IS; Birioukova LM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2014; 64(6):668-85. PubMed ID: 25975143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Gender-Biased Effects of Intranasal MPTP Administration on Anhedonic- and Depressive-Like Behaviors in C57BL/6 Mice: the Role of Neurotrophic Factors.
    Schamne MG; Mack JM; Moretti M; Matheus FC; Walz R; Lanfumey L; Prediger RD
    Neurotox Res; 2018 Nov; 34(4):808-819. PubMed ID: 29808370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive exploration of a novel rat model of Parkinson's disease using partial 6-hydroxydopamine lesion of dopaminergic neurons suggests new therapeutic approaches.
    Vetel S; Sérrière S; Vercouillie J; Vergote J; Chicheri G; Deloye JB; Dollé F; Bodard S; Tronel C; Nadal-Desbarats L; Lefèvre A; Emond P; Chalon S
    Synapse; 2019 Mar; 73(3):e22077. PubMed ID: 30368914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
    Aponso PM; Faull RL; Connor B
    Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressive-like neurochemical and behavioral markers of Parkinson's disease after 6-OHDA administered unilaterally to the rat medial forebrain bundle.
    Kamińska K; Lenda T; Konieczny J; Czarnecka A; Lorenc-Koci E
    Pharmacol Rep; 2017 Oct; 69(5):985-994. PubMed ID: 28843848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency stimulation of subthalamic nucleus results in behavioral recovery by increasing striatal dopamine release in 6-hydroxydopamine lesioned rat.
    He Z; Jiang Y; Xu H; Jiang H; Jia W; Sun P; Xie J
    Behav Brain Res; 2014 Apr; 263():108-14. PubMed ID: 24462728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course study of microglial and behavioral alterations induced by 6-hydroxydopamine in rats.
    Silva TP; Poli A; Hara DB; Takahashi RN
    Neurosci Lett; 2016 May; 622():83-7. PubMed ID: 27113204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats.
    Lima LAR; Lopes MJP; Costa RO; Lima FAV; Neves KRT; Calou IBF; Andrade GM; Viana GSB
    J Neuroinflammation; 2018 Aug; 15(1):249. PubMed ID: 30170624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hesperidin Ameliorates Anxiety-Depressive-Like Behavior in 6-OHDA Model of Parkinson's Disease by Regulating Striatal Cytokine and Neurotrophic Factors Levels and Dopaminergic Innervation Loss in the Striatum of Mice.
    Antunes MS; Cattelan Souza L; Ladd FVL; Ladd AABL; Moreira AL; Bortolotto VC; Silva MRP; Araújo SM; Prigol M; Nogueira CW; Boeira SP
    Mol Neurobiol; 2020 Jul; 57(7):3027-3041. PubMed ID: 32458386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis.
    Antunes MS; Ladd FVL; Ladd AABL; Moreira AL; Boeira SP; Cattelan Souza L
    Metab Brain Dis; 2021 Jan; 36(1):153-167. PubMed ID: 33057922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
    Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL
    J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.